Leveraging AI for Drug Discovery as a Biology Startup

10/01/2020 JLABS @ Toronto
Leveraging AI for Drug Discovery as a Biology Startup

Leveraging AI for Drug Discovery as a Biology Startup

Artificial Intelligence for healthcare is here to stay. Machine learning and AI have made it possible to search and develop new pharmaceuticals, faster, cheaper, and more effectively.

If you have a biology startup, it may seem obvious to leverage the power of AI to speed up your research – but just because you can, doesn’t mean you should.

Check out more On-Demand Webinars

Please note that this webinar was originally run on September 30, 2020.

You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email [email protected]

DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only.  This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates.  The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.

Related content